Share
Market Research Report

ASIA PACIFIC PHARMACEUTICAL CDMO MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By ProductsSmall Molecules · Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Others) · Gene Therapies · Cell Therapies (Autologous Cell Therapy Manufacturing and Allogeneic Cell Therapy Manufacturing) · and Others
  • By ServicesDrug Manufacturing Services · Drug Development Services · Packaging and Labelling Services · Quality Assurance and Regulatory Services · and Others
  • By Therapeutic AreaOncology · Cardiovascular Diseases · Neurology · Infectious Diseases · and Others
  • By End UserPharmaceutical and Biotechnology Companies · Academic Research Organizations · and Others
  • Published In16 Mar 2026
  • Report CodeCMI9373
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Asia Pacific Pharmaceutical CDMO Market, By Products
      • Asia Pacific Pharmaceutical CDMO Market, By Services
      • Asia Pacific Pharmaceutical CDMO Market, By Therapeutic Area
      • Asia Pacific Pharmaceutical CDMO Market, By End User
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trends
  4. Asia Pacific Pharmaceutical CDMO Market, By Products, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Small Molecules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Biologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Monoclonal Antibodies (mAbs)
        • Recombinant Proteins
        • Vaccines
        • Others
    • Gene Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Cell Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Autologous Cell Therapy Manufacturing
        • Allogeneic Cell Therapy Manufacturing
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Asia Pacific Pharmaceutical CDMO Market, By Services, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Drug Manufacturing Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Drug Development Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Packaging and Labelling Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Quality Assurance and Regulatory Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Asia Pacific Pharmaceutical CDMO Market, By Therapeutic Area, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Neurology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Asia Pacific Pharmaceutical CDMO Market, By End User, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Academic Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Competitive Landscape

    • WuXi AppTec
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi STA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Samsung Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Piramal Pharma Solutions
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Syngene International
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Jubilant Biosys
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Asymchem Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bora Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Laurus Labs
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bushu Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CMIC CMO
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Almac Pharma Services Asia
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Porton Pharma Solutions
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GenScript ProBio
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Pharmaceutical CDMO Market' - Asia Pacific forecast to 2033